Dihon Acquisition Doubles Bayer’s Consumer Health Presence In China
This article was originally published in The Tan Sheet
Executive Summary
Bayer acquired its second Chinese consumer health care firm to gain market share amid the country’s OTC consolidation trend. Dihon specializes in antifungal creams and herbal drugs for women’s and traditional Chinese medicines.
You may also be interested in...
Bayer Leveraging Consumer Growth From Product Launches, More Shelf Space
Global consumer chief Erica Mann says OTC drug and nutritional product sales should increase during the current quarter as consumers' self-care focus turns to sunscreens and allergy treatments. Bayer plans around 30 consumer product launches later in the year.
Bayer Leveraging Consumer Growth From Product Launches, More Shelf Space
Global consumer chief Erica Mann says OTC drug and nutritional product sales should increase during the current quarter as consumers' self-care focus turns to sunscreens and allergy treatments. Bayer plans around 30 consumer product launches later in the year.
Business & Finance Roundup: Bayer, NutraFuels, Symrise
Bayer expands manufacturing in China; Florida supplement firms merge; and more news in brief.